|
| Status |
Public on Jun 06, 2024 |
| Title |
A combination treatment based on drug repurposing demonstrates mutation agnostic efficacy in pre-clinical retinopathy models. |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| Web link |
https://www.nature.com/articles/s41467-024-50033-5
|
| |
|
| Citation(s) |
39009597 |
| |
| Submission date |
Jul 25, 2023 |
| Last update date |
Aug 09, 2024 |
| Contact name |
Henri Leinonen |
| E-mail(s) |
henri.leinonen@uef.fi
|
| Phone |
00358504303196
|
| Organization name |
University of Eastern Finland
|
| Department |
School of Pharmacy
|
| Street address |
Yliopistonranta 1
|
| City |
Koupio |
| ZIP/Postal code |
70210 |
| Country |
Finland |
| |
|
| Platforms (2) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (40)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE234797 |
A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models [scRNA-seq: Rd10] |
| GSE238216 |
A combination treatment based on drug repurposing demonstrates mutation agnostic efficacy in pre-clinical retinopathy models. [RNA-seq: RPE65-KO] |
| GSE238217 |
A combination treatment based on drug repurposing demonstrates mutation agnostic efficacy in pre-clinical retinopathy models. [RNA-seq: Rd10] |
| GSE263877 |
A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models [scRNA-seq: Rpe65-KO] |
|
| Relations |
| BioProject |
PRJNA998379 |
Less...
More...